Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Acquires Molecular Staging s Amplification Technology for $28.5M

NEW YORK, Sept. 27 (GenomeWeb News) - Qiagen today said that it has acquired technology assets from Molecular Staging, including the company's whole-genome amplification and rolling-circle amplification technologies, for $28.5 million.

           

Under the terms of the agreement, Qiagen purchased the technology assets of MSI, including more than 160 applied or issued patents, for $28.5 million in cash plus potential earn-outs of up to $6.75 million.

 

Qiagen said it expects to incur one-time charges relating to the acquisition of around $2 million in the third quarter of 2004, and that it expects the acquisition to add approximately $6 million in net sales and $1 million in net income in 2005.

 

The company said it plans to launch a series of kits integrating the WGA technology with its own nucleic acid products by early 2005.

 

Molecular Staging's WGA activities will be integrated into Qiagen's operations in Germantown, Md., and Hilden, Germany.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.